000 01210 a2200337 4500
005 20250517003437.0
264 0 _c20150122
008 201501s 0 0 ger d
022 _a1439-4413
024 7 _a10.1055/s-0034-1387406
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanefeld, M
245 0 0 _a[Modern medical treatment of type 2 diabetes].
_h[electronic resource]
260 _bDeutsche medizinische Wochenschrift (1946)
_cDec 2014
300 _a2494-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aGlucagon-Like Peptide 1
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aInsulin Detemir
650 0 4 _aInsulin, Long-Acting
650 0 4 _aPatient-Centered Care
650 0 4 _aPractice Guidelines as Topic
700 1 _aBornstein, S R
700 1 _aBarthel, A
773 0 _tDeutsche medizinische Wochenschrift (1946)
_gvol. 139
_gno. 49
_gp. 2494-7
856 4 0 _uhttps://doi.org/10.1055/s-0034-1387406
_zAvailable from publisher's website
999 _c24378982
_d24378982